Back to BARCLAYS PLC BARCLAYS PLC

BBIOBBIO
Showing 8 of 29 quarters

Position history for BARCLAYS PLCBARCLAYS PLC's holdings in BRIDGEBIO PHARMA INC

BARCLAYS PLC holds 714,423 shares of BBIO (BRIDGEBIO PHARMA INC), worth $53.2M as of 2026-Q2. The position was increased (+68.5% shares). BBIO represents 0.0% of BARCLAYS PLC's portfolio.

Current Value

$53.2M

Current Shares

714,423

Total Value Change

+$39.3M

Total Shares Change

+169,415

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
714,423
+68.5%
$53.2M0.0%$74.48
43
2026-Q1
Decreased
423,888
-31.9%
$31.5M0.0%$74.26
0
2025-Q4
Decreased
622,575
-13.5%
$47.6M0.0%$76.49
0
2025-Q3
Decreased
719,448
-22.9%
$37.4M0.0%$51.94
0
2025-Q2
Increased
933,512
+140.1%
$40.3M0.0%$43.18
47
2025-Q1
Decreased
388,838
-13.1%
$13.4M0.0%$34.57
0
2024-Q4
Decreased
447,510
-17.9%
$12.3M0.0%$27.44
0
2024-Q3
Increased
545,008
+31.9%
$13.9M0.0%$25.46
36

Other major holders of BBIO: VIKING GLOBAL INVESTORS LP, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used